Loading quotes...

Forecast

The analysts' average price target is €30.17 (-3.61%). The median is €28.13 (-10.13%).

Buy
  8
Hold
  7
Sell
  0

Discussions in the community

There is no discussion about this asset yet.

Start discussion

  • Double downgrade drives Trupanion stock sharply lower

    The stock of Trupanion fell about 6.4% in morning trading after Piper Sandler cut its rating from "Overweight" to "Neutral" and lowered the price target from $45 to $32. Piper Sandler cited declining puppy vet visits and more costly, aging COVID cohorts as headwinds for premium growth and underwriting margins. A simultaneous downgrade by Zacks intensified the sell-off, while the new price target, near the current share price, signals only limited short-term upside. » More on de.investing.com


  • Trupanion beats Q2 earnings forecast and highlights outlook for 2026

    Trupanion reported Q2/2026 earnings of $0.16 per share, beating the $0.1133 forecast, on revenue up 11% to $392.9m. Adjusted operating income from subscriptions rose 24% and subscription revenue grew 14% to $276.7m, while the number of insured pets increased 5% to 1.125m. The stock rose 6.7% after hours; management confirmed a 2026 revenue range of $1.584–1.601bn and adjusted operating income of $176–184m. Risks remain higher customer acquisition costs, ongoing veterinary price inflation and execution risks for new product options. » More on de.investing.com


  • Trupanion reaches 52-week low at $24.13

    Trupanion shares fell to a 52-week low of $24.13 after losing about 34% over the past year and roughly 40% in recent months. For Q4 2025 the company reported earnings per share of $0.13 (forecast $0.16) and revenue of $376.9 million (+12% year over year), slightly beating expectations. Analysts cut price targets (Cantor Fitzgerald 42→34 USD, Stifel 35→31 USD) citing growth and scaling concerns, while InvestingPro signaled possible undervaluation and upside; Trupanion also announced a research collaboration with the Human Animal Bond Research Institute. » More on de.investing.com


  • Trupanion falls to 52-week low of $24.30

    Trupanion shares hit a new 52-week low at $24.30, down about 31.7% year-to-date; the six-month performance is down nearly 38%. The company reported Q4 2025 EPS of $0.13 (expectation $0.16) on revenue of $376.9 million (+12% YoY, forecast $375.21 million). Analysts cut price targets (Cantor Fitzgerald 42 → 34 USD, Stifel 35 → 31 USD), citing growth and scaling issues, while InvestingPro sees an undervaluation of around 38% and expects profitability this year. Trupanion also announced a partnership with the Human Animal Bond Research Institute to support studies on human-animal relationships. » More on de.investing.com


  • Trupanion hits 52-week low after sharp share decline

    Trupanion shares closed at $24.49, marking a 52-week low after declines of 33.06% over the past year, 43% in six months and 31% year-to-date. Investors are worried about slowing growth and competitive pressure in the pet insurance industry, although a PEG of 0.19 suggests possible undervaluation. In Q4 2025, Trupanion missed the EPS expectation (0.13 vs. $0.16) while revenue rose 12% to $376.9 million; a partnership with the Human Animal Bond Research Institute was also announced. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics
In 2022, Trupanion has already paid €0.0078 in dividends. The last payout was in April 2022.

Financials

In the last quarter, Trupanion had revenue of €358.08M and net profit of €8.19M
(EUR) September 2026
YoY
Revenue 358.08M 14.52%
Gross profit 61.36M 19.90%
Net profit 8.19M 63.74%
EBITDA 14.03M 22.48%

Fundamentals

Metric Value
Market capitalization
€1.35B
Number of shares
43.27M
52-week high/low
€35.27 - €19.20
Dividends No
Beta
1.30
P/E ratio
56.52
PEG ratio
0.76
P/B ratio
3.77
P/S ratio
0.96

Company profile

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.

Name
Trupanion
CEO
Margaret Rosemary Maria Tooth
Headquarters Seattle, wa
USA
Website
Sector
Financials
Industry
Insurance
IPO
07/18/2014
Employees 1,121

Ticker symbols

Exchange Symbol
NASDAQ
TRUP
London Stock Exchange
0LH0.L
Frankfurt
TPW.F
Düsseldorf
TPW.DU
London
0LH0.L
SIX
TPW.SW
München
TPW.MU
🍪

Parqet  uses cookies. Learn more